(Q40588136)

21 September 2017

1 reference

title

New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

21 September 2017

0 references

1 reference

R P Rapp

1

1 reference

21 September 2017

S A McCraney

series ordinal

2

1 reference

21 September 2017

N L Goodman

series ordinal

3

1 reference

21 September 2017

D J Shaddick

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

Annals of Pharmacotherapy

21 September 2017

published in

1 reference

21 September 2017

volume

28

1 reference

21 September 2017

issue

11

1 reference

21 September 2017

page(s)

1255-1263

1 reference

Mycobacterial Diseases Other Than Tuberculosis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Antimicrobial strategies in the care of organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Mycobacterium marinum infections in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Pulmonary infection with mycobacterium xenopi: review of treatment and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Intraphagocytic penetration of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Legionnaires disease: historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Azithromycin: the first azalide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Clinical toleration and safety of azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Antibiotic entry into human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Intracellular accumulation of azithromycin by cultured human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

In vitro and in vivo activities of clarithromycin against Mycobacterium avium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Mycobacterium avium complex infection and AIDS: advances in theory and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Mycobacterium chelonaeCausing Otitis Media in an Ear-Nose-and-Throat Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Two Outbreaks of Sternal Wound Infections Due to Organisms of the Mycobacterium fortuitum Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Disseminated infection with rapidly growing mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801109

10.1177/106002809402801109

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference